Cellex Cell Professionals
About us
Cellex is an end-to-end CDMO based in Cologne, Germany with 10+ years’ experience in manufacturing autologous & allogenic cell and gene therapy (CGT) products. We support customers from preclinical development stages through clinical manufacturing to commercialization. Currently, Cellex is manufacturing several final drug products (FDPs) and cellular intermediates (ITMs) including commercial products. In addition, Cellex offers customized starting materials from healthy donors and patients affected by specific conditions for research, clinical and commercial purposes as well as GDP-compliant logistics services for cellular materials.
• 10+ years’ experience in CGT
• 50,000+ performed cell collections for CGT and SCT
• 10+ manufacturing licenses for autologous & allogenic CGT
• Manufacturing of cellular intermediates & final drug products
• Involved in manufacturing 3 approved CAR-T therapies
• 4,500+ manufactured CGT batches
• >27,000 sq ft GMP manufacturing area
• 350+ Cellex experts working and growing together
Address
Melli-Beese-Str. 9-11
50829 Cologne
Germany
E-mail: businessdevelopment@cellex.me
Phone: +49 221 25092633
Internet: www.cellex.me/en
Contact person:
Julie Daigre
Manager Business Development
E-mail: j.daigre@cellex.me
Phone: +49 1512 2663809
Oliver Gresch
Global Key Account Lead
E-mail: o.gresch@cellex.me
Phone: +49 1604 464227
Products & Services
CDMO Services for CGT
Full GMP manufacturing service for autologous and allogeneic cell therapy products
Cryopreservation and storage
EU QP services
Process development and optimization
GDP-compliant supply chain and logistics
High-Quality Starting Materials
Customized healthy and diseased donor materials
Leukopaks, G-CSF Mobilized Leukopaks, G-CSF Mobilized Whole Blood, Cord Blood, Bone Marrow, Whole Blood
Fresh & Cryopreserved
For research, clinical, and commercial use
Patient apheresis for sponsors
Consultancy Services
Implementation of EMA and FDA guidelines
End-to-end consultancy in the CGT field
Advice on integrating new technologies and genetic manipulation
Qualification of apheresis centers
Support for clinical studies, from setup to execution, including seamless GxP interface management with your CRO